INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 201 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 1.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25 | +13.6% | 1,384 | -31.7% | 0.00% | – |
| Q2 2023 | $22 | -95.2% | 2,027 | -94.1% | 0.00% | – |
| Q1 2023 | $462 | -99.2% | 34,462 | +753.9% | 0.00% | – |
| Q3 2022 | $56,000 | +273.3% | 4,036 | +270.3% | 0.00% | – |
| Q2 2022 | $15,000 | -94.2% | 1,090 | -93.2% | 0.00% | – |
| Q1 2022 | $259,000 | +600.0% | 15,950 | +963.3% | 0.00% | – |
| Q4 2020 | $37,000 | -40.3% | 1,500 | 0.0% | 0.00% | – |
| Q3 2020 | $62,000 | -12.7% | 1,500 | 0.0% | 0.00% | – |
| Q2 2020 | $71,000 | -95.8% | 1,500 | -89.0% | 0.00% | -100.0% |
| Q4 2019 | $1,689,000 | +859.7% | 13,634 | +412.7% | 0.00% | +300.0% |
| Q3 2019 | $176,000 | -91.6% | 2,659 | -85.8% | 0.00% | -83.3% |
| Q1 2019 | $2,095,000 | +391.8% | 18,729 | +342.7% | 0.01% | +500.0% |
| Q4 2018 | $426,000 | -70.7% | 4,231 | -63.2% | 0.00% | -80.0% |
| Q3 2018 | $1,453,000 | +179.4% | 11,502 | +85.4% | 0.01% | +150.0% |
| Q2 2018 | $520,000 | +6.8% | 6,203 | -21.8% | 0.00% | -90.5% |
| Q1 2018 | $487,000 | +116.4% | 7,931 | +105.7% | 0.02% | +110.0% |
| Q4 2017 | $225,000 | -46.0% | 3,856 | +11.8% | 0.01% | -44.4% |
| Q2 2017 | $417,000 | -32.3% | 3,448 | -36.7% | 0.02% | -33.3% |
| Q1 2017 | $616,000 | -51.2% | 5,447 | -53.1% | 0.03% | -64.0% |
| Q4 2016 | $1,262,000 | -46.3% | 11,619 | -29.4% | 0.08% | -52.2% |
| Q2 2016 | $2,349,000 | +221.3% | 16,469 | +236.2% | 0.16% | +175.4% |
| Q4 2015 | $731,000 | +31.7% | 4,899 | +46.3% | 0.06% | +39.0% |
| Q3 2015 | $555,000 | -40.3% | 3,348 | -13.0% | 0.04% | -47.4% |
| Q2 2015 | $929,000 | -58.5% | 3,849 | -51.5% | 0.08% | -70.0% |
| Q1 2015 | $2,236,000 | – | 7,929 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |